microdosing with glp 1 THE PCCA BLOG Microdosing GLP-1s: How (and Why)

KLOW Synergies & Stacking Can KLOW be stacked with NAD+

First, a substantial portion of the mechanistic and translational data derives from preclinical studies or small human cohorts, which may not fully capture understudied aspects of aging that vary across populations

However, analysis of trial data from five long-acting GLP-1 agonists (exenatide once weekly, taspoglutide, albiglutide, LY2189265 and CJC-1134-PC) revealed that they were more likely than shorter-acting formulations to raise the heart rate (Robinson et al., 2013)

Rosenkilde, MM (July 2021) 'The role of incretins on insulin function and glucose homeostasis', Endocrinology , 162/7, bqab065